Unique ID issued by UMIN | UMIN000026760 |
---|---|
Receipt number | R000030723 |
Scientific Title | A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients withsmall vessel disease |
Date of disclosure of the study information | 2017/03/29 |
Last modified on | 2017/03/29 16:32:58 |
A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients withsmall vessel disease
A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients withsmall vessel disease
A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients withsmall vessel disease
A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients withsmall vessel disease
Japan |
Coronary artery disease
Cardiology |
Others
NO
To compare the safety and efficacy of paclitaxel-coated balloon with plain balloon for coronary artery small vessel disease
Safety,Efficacy
Target vessel failure
Procedural success
Clinical success
MACE
TLR
Restenosis
Late lumen loss
Interventional
Parallel
Randomized
Individual
Single blind -participants are blinded
Placebo
2
Treatment
Device,equipment |
Paclitaxel-coated balloon
Plain balloon
20 | years-old | <= |
Not applicable |
Male and Female
Stable or unstable angina or asymptomatic myocardial ischemia
Patients who met the treatment criteria for PCI
RVD 2.0mm or larger and <2.75 mm with lesions length <22mm
Stenosis of the native coronary artery
>50% and <100%
Acute myocardial infarction within 72 hour after onset; acute cardiac failure; pregnancy or lactation; renal dysfunction (serum creatinine >1.5 mg/dl); low left ventricular function (left ventricular ejection fraction <30%)
Contraindications or known intolerance to antiplatelet agents, paclitaxel, or contrast agents
Lesions in the left main branch; patients meeting the criteria for coronary artery bypass graft (CABG); lesions 2mm or shorter from a bifurcation; multiple lesions in a single branch; patients with highly calcified lesions that were difficult to dilate with a balloon; high-grade bend lesions 90% or more;
Previously undergone placement of a paclitaxel-eluting stent or had undergone DES placement within the preceding 24 weeks
135
1st name | |
Middle name | |
Last name | Atsushi Funatsu |
Kyoto Katsura hospital
Cardiovascular center
Yamadahirao-cho, Nishikyo-ku, Kyoto city
075-382-3185
kcvc.funatsu@katsura.com
1st name | |
Middle name | |
Last name | Noriko Fujita |
Kyoto Katsura hospital
Clinical reserch center
Yamadahirao-cho, Nishikyo-ku, Kyoto city
075-391-5811
noriko.fujita@katsura.com
Nipro Corporation
Nipro Corporation
Profit organization
Japan
NO
2017 | Year | 03 | Month | 29 | Day |
Unpublished
Completed
2009 | Year | 07 | Month | 23 | Day |
2009 | Year | 10 | Month | 01 | Day |
2017 | Year | 03 | Month | 29 | Day |
2017 | Year | 03 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030723